Skip to content

Validity of intravenous indocyanine green injection as a diagnostic tool for soft tissue assessment in shoulder and elbow arthroscopic surgery

Validity of intravenous indocyanine green injection as a diagnostic tool for soft tissue assessment in shoulder and elbow arthroscopic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007820
Enrollment
110
Registered
2022-10-19
Start date
2021-05-24
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : - case group: The group that used ICG during surgical procedure to distinguish the blood perfusion tissue - Control group: a group that performed surgery according to the traditio

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with chronic or recurrent lateral epicondylitis of the main node corresponding to indications for surgery 2) Patients with rupture of the rotator cuff of the shoulder joint corresponding to surgical treatment indications 3) Patients with systemic diseases who do not have a reason for disqualification from surgery and contrast agent injection 4) Patients who are willing to voluntarily agree in writing after receiving an explanation of the purpose, method, etc. of this study, comply with the test plan, and are willing to visit the hospital for the evaluation of observation items.

Exclusion criteria

Exclusion criteria: 1) Patients with inflammatory or rheumatoid arthritis 2) Patients with joint stiffness due to deformation of the humerus, radial bone, and ulnar bone that make up the main section 3) Patients with advanced arthritis who are indications for joint replacement 4) Patients with observed soft tissue lesions other than lateral epicondylitis 5) Patients with soft tissue lesions other than shoulder joint rotator cuff rupture observed 6) Those who have been diagnosed with the following diseases and find it difficult to proceed with the operation A. Uncontrolled diabetes, high blood pressure B. Severe mental illness c. Severe cirrhosis, renal failure, heart failure 7) Those who are deemed inappropriate for clinical trials by the investigator responsible for the trial or other researchers 8) Patients who are not suitable for the administration of indocyanin green A. Patients with a predisposition of hypersensitivity to the present drug B. Patients with iodine hypersensitivity C. Patients with a predisposition to allergies

Design outcomes

Primary

MeasureTime frame
Semi-quantitative analysis of the difference of enhancement of ICG.

Secondary

MeasureTime frame
post operative pain, range of motion, healing rate of surgical site

Countries

Korea, Republic of

Contacts

Public ContactJun-Bum Lee

Asan Medical Center

lsjb715@gmail.com+82-2-3010-1856

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026